Collagen Supplement Regulations: What Every Brand Must Know

Most collagen supplements sold in the EU are classified as food supplements containing hydrolysed collagen peptides. Standard collagen peptides from bovine, porcine, or marine sources are generally permitted as food ingredients in the EU with a long history of safe use. However: (1) Specific collagen peptide preparations with novel manufacturing processes or novel sources may trigger Novel Food review under EU 2015/2283. (2) Health claims about skin, joint, or bone benefits are not authorised on the EU Authorised Health Claims register — brands cannot claim 'improves skin elasticity' or 'reduces joint pain'. Only generic claims about protein (collagen is a protein) can be made.

In the US, collagen supplements fall under DSHEA as dietary supplements. Structure/function claims are permitted with the standard disclaimer: 'This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.' Common US collagen claims: 'supports skin elasticity', 'supports joint health', 'contributes to muscle recovery' — all acceptable as structure/function claims. Collagen protein from novel sources (insect collagen, engineered collagen) may require New Dietary Ingredient (NDI) notification.

Japan is the world's largest and most sophisticated collagen supplement market. Japanese consumers have consumed collagen beauty supplements for decades — collagen drinks, collagen gummies, and collagen peptide sachets are mainstream consumer products. Japan's FFC (Food with Function Claims) system allows claims about skin condition and joint support backed by systematic review. Japanese consumers are sophisticated about collagen molecular weight (low-MW hydrolysed peptides preferred), source (marine collagen popular for purity perception), and flavour.

In Australia, collagen supplements making skin or joint health claims may trigger TGA classification as therapeutic goods requiring ARTG listing. General protein claims (collagen as a protein source) keep the product in FSANZ food territory. Marine collagen from certain sources requires import biosecurity clearance from DAFF. Bovine collagen triggers TSE/BSE source documentation requirements.

Across all major markets, bovine collagen requires Transmissible Spongiform Encephalopathy (TSE/BSE) safety documentation. Required in EU, UK, Japan, Australia, and most ASEAN markets: Certificate of Origin for bovine raw material, declaration that sourcing is from BSE-free herds or low-risk countries, and often third-party testing for absence of prions. Marine collagen avoids this complexity and is growing in preference globally.